Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A study published in Radiology found that MRI-detected multicentric cancers are larger and potentially more aggressive than index cancers detected by mammography, necessitating treatment changes. In 25% of cases, these multicentric cancers were over 1 centimeter in size.
A recent EORTC study identified key health-related quality of life (HRQOL) components to prioritize in caring for older cancer patients. The study found that HRQOL improves with age for social functioning and financial problems, while physical functioning and constipation worsen.
A preclinical study finds that AR-42, an HDAC inhibitor, preserves muscle health and function while stopping life-threatening muscle wasting associated with advanced cancers. The experimental agent was shown to have a strong protective effect against tumor-associated muscle wasting in two preclinical models.
The Translational Oncology Initiative aims to connect scientists and clinicians to develop life-saving therapies for cancer patients. The 'Trojan Horse' therapy uses a virus hidden in immune cells to destroy cancer cells from within.
A new template published by ASTRO streamlines post-treatment care for cancer survivors, facilitating consistency and reducing provider burden. The template includes elements required by CoC accreditation requirements, coordinating care among primary care providers, radiation specialists, and patients.
Researchers found that combinations of non-toxic chemicals, many derived from plants and foods, may stop untreatable cancers and prevent disease relapses. The task force identified 74 molecular targets with potential anti-cancer effects, paving the way for low-cost therapies.
Researchers at the University of Montreal Hospital Research Centre have developed a new injectable biogel that can deliver anti-cancer agents directly into cancerous tumours. The biogel is effective in killing cancer cells and has shown promising results in laboratory tests, including the destruction of melanoma and kidney cancer cells.
Researchers analyzed genomic data from 1,120 pediatric cancer patients and found that 8.5% had pathogenic germline mutations in cancer predisposition genes. This study suggests that comprehensive genomic screening may be necessary for all pediatric cancer patients, not just those with a family history of cancer.
A global task force of 180 scientists has identified high-priority molecular targets for improved patient outcomes in most cancers. The team recommends low-toxicity approaches using non-toxic chemicals, including those found in plants and foods, to reach a broad-spectrum of priority targets.
A novel immunotherapeutic approach, personalized peptide vaccination, showed significant improvement in overall survival for patients with advanced bladder cancer. The study found a median overall survival of almost twice as long as that for patients without the treatment, at 7.9 months versus 4.1 months.
A recent study found that 8.5% of children with cancer have genetic mutations increasing their risk, highlighting the need for improved counseling and family testing. The study's author, Dr. John M. Maris, emphasizes the importance of understanding how other genes interact with these mutations to cause cancer in children.
A broad-spectrum approach to cancer treatment and prevention is being developed by researchers, focusing on low-toxicity agents from plants and foods that target multiple pathways involved in cancer development. The approach aims to improve upon current targeted therapies and reduce costs associated with toxicity and treatment duration.
A meta-analysis of traditional Chinese medicine and nonpharmacological interventions found that they alleviate symptoms such as depression, fatigue, and pain in Chinese cancer patients. These interventions include acupuncture, therapeutic massage, stress management, cognitive behavioral therapy, and physical training.
Men with prostate cancer who undergo radiation therapy can benefit from yoga, which stabilizes fatigue, sexual health, and urinary incontinence. Yoga also improves general quality of life by reducing cancer-related fatigue and strengthening pelvic floor muscles.
African-American women with a healthier diet, based on the Alternate Healthy Eating Index-2010 (AHEI-2010), were 34% less likely to be diagnosed with ovarian cancer. The study found that higher vegetable intake and lower intake of empty calories contributed to the reduced risk.
Early-stage non-small cell lung cancer patients receive varying levels of curative-intent surgery across US states, with disparities seen by race and socioeconomic factors. The study found that Massachusetts had the highest rates of curative surgery, while Wyoming had the lowest rate at 25%.
A new study analyzed 527 patients who underwent spinal fusion surgery using recombinant human bone morphogenetic protein (rhBMP) and found high rates of successful fusion and low rates of complications. The study found no significantly increased risk of cancer, contradicting previous concerns.
A study found that kidney failure patients on dialysis were at high risk of kidney and thyroid cancers, while those post-transplant were at higher risk of non-Hodgkin lymphoma and melanoma. The findings highlight the importance of cancer screening and prevention in these patients.
Dr. Electra Paskett receives AACR Distinguished Lecture on Cancer Health Disparities for her decades-long contributions to reducing cancer health disparities among underserved populations. Her work has led to critically important improvements in cancer screening and care, earning her international recognition as a leader in the field.
A phase I clinical trial found that pevonedistat, a small-molecule inhibitor of the NEDD8-activating enzyme, was safe and tolerable in heavily pretreated patients with relapsed/refractory lymphoma. The therapeutic showed modest activity in these patients, with three achieving partial responses and 30 experiencing stable disease.
Researchers from the University of Leicester have announced a breakthrough advance in treating chronic lymphocytic leukemia and non-Hodgkin lymphoma patients who are refractory or resistant to current chemotherapies. The new drug, ONO/GS-4059, targets BTK protein and has shown promising results with minimal toxicities.
A new blood test can detect when breast cancers become resistant to standard hormone treatment, allowing for early identification and alternative treatment options. Researchers developed the test to identify ESR1 mutations, which convey resistance to hormone treatment.
Researchers recommend hospitals create bereavement programs to support families through grief, preventing physical and mental health problems. The Dana-Farber Cancer Institute's program has shown positive effects, including a reduction in dysfunctional bereavement and its associated health issues.
A new study links high-temperature cooking of red and white meat to increased risk of kidney cancer, citing the presence of carcinogenic compounds such as PhIP and MeIQx. The study suggests that reducing meat consumption, especially when cooked at high temperatures, may help mitigate this risk.
Researchers discovered brain cancer cells form a complex network to resist treatment and invade healthy brain tissue. The tumor cells use this network to communicate and repair damage, making it resistant to radiation therapy.
A genetic biomarker called loss of heterozygosity (LOH) predicts which patients with premalignant mouth lesions are at highest risk of developing oral cancer. The study found that LOH-positive patients had a three-year cancer-free survival rate of 74% compared to 87% for LOH-negative patients.
Researchers at Ohio State University discovered a key molecule that enables cancer cells to produce lipids, leading to rapid tumor growth. Blocking this molecule may slow tumor growth and provide new therapeutic strategies for glioblastoma and other cancers.
A new clinical trial is proposed to investigate the best ways for identifying and treating advanced breast cancer patients who can survive for long periods without their disease progressing. The guidelines emphasize the importance of harnessing technology to improve cancer treatment, particularly for patients in remote areas.
A team of top researchers, led by TGen's Dr. Daniel D. Von Hoff, aims to develop therapies that greatly improve patient survival. They will focus on reprogramming the 'super enhancers' in cancer cells to stop tumor growth and offer novel treatments for patients with pancreatic cancer.
A team of top researchers will focus on reprogramming pancreatic tumor biology using cutting-edge technology and developing new SE-targeted drugs. The goal is to dial up sensitivity to chemotherapy and push tumors into lasting remission.
A genetic biomarker called loss of heterozygosity (LOH) predicts which patients with premalignant mouth lesions are at highest risk of developing oral cancer. The study found that LOH-positive patients had a lower three-year cancer-free survival rate, but no benefit from erlotinib treatment.
A phase 2 study found that 42% of older patients with acute myeloid leukemia (AML) can remain cancer-free after reduced-intensity stem cell transplantation, challenging traditional age-based exclusion criteria. This approach may offer improved outcomes for AML patients over 60 with otherwise well-tolerated treatments.
Researchers found that analyzing circulating tumor DNA can track a patient's cancer evolution and identify the best treatments. The liquid biopsy test is less invasive and less costly than conventional tissue biopsies, providing up-to-date information on how a patient's cancer is changing.
Research found that average survival was less than six months, with only 36% surviving beyond one year. Patients diagnosed through emergency routes tend to have more advanced cancers, contributing to a poorer prognosis. The study highlights the importance of early diagnosis in improving cancer survival rates.
Ahnna Parkhurst, a 15-year-old racing prodigy, is raising awareness and research dollars for the Translational Genomics Research Institute (TGen) through Laurie's Fund. Her efforts have raised over $111,000 to support cancer research and treatments.
Despite progress, cancer care in Latin America remains hindered by significant gaps in public expenditure on health and cancer care. The region still faces major challenges, including limited palliative care services, inadequate training in pain management, and underutilization of new technologies.
The FDA has approved talimogene laherparepvec (T-VEC), a herpes cold sore virus designed to kill tumor cells, as a treatment for late-stage melanoma. The therapy showed a durable response in 16% of patients, with some experiencing no signs of cancer after treatment.
A new study of over 25,000 men has identified four new genetic variants associated with an increased risk of testicular cancer. Testing for these variants combined with existing knowledge has revealed that men in the top one per cent of genetic risk have a ten-fold elevated risk of developing testicular cancer.
A retrospective survival analysis of 229 patients with late-stage cancer found that those who received methylnaltrexone lived twice as long and had fewer tumor progression reports compared to placebo groups. The study suggests methylnaltrexone may play a role in cancer therapy, but the exact mechanism is unclear.
A new collaborative research project, ISIBELa, is investigating the risk of secondary cancer in later life following successful childhood cancer therapy. Researchers will analyze cases, examine patient differences, and use advanced laboratory techniques to identify genetic and epigenetic causes.
The USPSTF recommends screening overweight and obese adults between 40-70 for abnormal blood sugar, referring those with high blood sugar to intensive behavioral counseling. Abnormal blood sugar levels increase risk of developing type 2 diabetes, which has risen in prevalence over the past 15 years.
Scientists at Sanford Burnham Prebys Medical Discovery Institute used publicly available cancer databases to identify novel cancer driver genes associated with cancer progression. The study found 71 previously unrecognized interfaces in proteins that may serve as new predictive markers or drug targets.
A multicomponent outreach program increased completion of the three-dose HPV vaccination series in adolescent girls, with mixed results by race/ethnicity. The study found that HPV vaccine-specific educational materials were effective for Hispanic parents, but not for African-American parents.
Three NIH-funded studies found that a genetic mutation linked to ALS and FTD impairs nuclear transport in neurons, leading to defects in gene expression. Researchers suggest therapies targeting nucleocytoplasmic transport may be effective in treating these diseases.
A team of scientists analyzed high-throughput sequencing data from 538 CLL patients and identified 44 genes that are frequently mutated in the disease. These mutations, known as driver mutations, affect RNA processing, MYC activity, and MAPK signaling.
Scientists have developed a blood test that can pair cancer patients with the most suitable therapy for their disease, giving real-time updates on tumor progression. This approach could make diagnosis, treatment, and monitoring quicker, cheaper, and less invasive.
Researchers have discovered a new gene, snoRNA42, linked to an increased risk of bowel cancer recurrence and shortened survival. This gene may serve as a reliable biomarker for selecting high-risk patients who can benefit from personalized treatments.
A new five-gene signature, MG5, identifies high-risk children with aggressive forms of the disease, suggesting personalized treatment options. The test has been validated in samples from 68 patients and could lead to improved survival rates and reduced side effects.
Scientists developed a test to identify patients at risk of relapse from non-seminomatous germ cell tumour. The test assessed three features: CXCL12 levels, cancer stem cells, and blood vessel presence. It divided patients into three risk groups, with the low-risk group experiencing high relapse-free survival rates.
A study found that a specific gene signature called MG5 can divide intermediate-risk rhabdomyosarcoma patients into two separate risk groups. Those with high MG5 scores had poorer survival outcomes and were seven times more likely to die of the disease.
A recent study by researchers at King's College London found that general practices using the urgent referral pathway (two-week wait system) have lower cancer mortality rates compared to those that rarely use this pathway. Increasing its use could improve patient survival, especially for patients from low-referring practices.
A study by Cancer Research UK and King's College London found that cancers diagnosed at a later stage have higher mortality rates, with death rates increasing by seven per cent in practices using the two-week referral route least often. Increasing GP cancer awareness could help reduce deaths.
Researchers identified four consensus molecular subtypes of bowel cancer, allowing doctors to treat each type differently. The study has implications for identifying patients at risk of developing more serious disease and tailoring treatments.
Researchers at Georgetown University Medical Center have discovered a compound that effectively controls the growth of EWS-FLI1-driven cancer cells in mice. The study found that YK-4-279 significantly reduced leukemia cell numbers and improved mouse health, suggesting potential as a therapeutic agent for various cancers.
A new study published in BMC Medicine found that dying at home is associated with a similar amount of pain compared to hospital deaths, and reduced grief for relatives. The study highlights the importance of access to comprehensive home care packages and facilitation of family caregiving.
A recent study published in JAMA Oncology examined cancer-care outcomes among US hospitals and found significant differences in long-term survival rates among four major categories of hospitals: PPS-exempt, NCI cancer centers, AMC, and other hospitals. The analysis revealed substantial gaps in survival rates, with patients treated at P...
Researchers discovered elephants have 38 additional modified copies of the p53 gene, which encodes a well-defined tumor suppressor. This unique genetic feature may protect elephants from cancer by enhancing their ability to kill damaged cells.
A recent study found that up to 90% of people in low-income countries lack radiotherapy treatment, leading to millions of deaths and lost economic benefits. Expanding access could save an estimated 26.9 million life-years by 2035.
Dan's House of Hope will receive the award to continue providing a place to live, programs, and home-away-from-home services for older adolescents and young adults with cancer. The organization helps reduce isolation, decrease financial burdens, and nourish hope for patients aged 15-39.
The ThriveWell Cancer Foundation will receive an $8,500 grant from the American Society for Radiation Oncology (ASTRO) to support its Patient Assistance Program. The program provides financial and transportation assistance to low-income cancer patients in San Antonio.